| Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis CJL Murray, KS Ikuta, F Sharara, L Swetschinski, GR Aguilar, A Gray, ... The lancet 399 (10325), 629-655, 2022 | 8107 | 2022 |
| In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation A Olivas-Martinez, JL Cárdenas-Fragoso, JV Jiménez, OA Lozano-Cruz, ... PloS one 16 (2), e0245772, 2021 | 186 | 2021 |
| Clinical and epidemiological characteristics of patients diagnosed with COVID-19 in a tertiary care center in Mexico City: a prospective cohort study E Ortiz-Brizuela, M Villanueva-Reza, MF Gonzalez-Lara, ... Revista de investigacion clinica 72 (3), 165-177, 2020 | 162 | 2020 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 57 | 2024 |
| Low thoracic skeletal muscle area is not associated with negative outcomes in patients with COVID-19 P Moctezuma-Velázquez, G Miranda-Zazueta, E Ortiz-Brizuela, ... American journal of physical medicine & rehabilitation 100 (5), 413-418, 2021 | 41 | 2021 |
| Diagnostic accuracy of antigen detection in urine and molecular assays testing in different clinical samples for the diagnosis of progressive disseminated histoplasmosis in … A Martínez-Gamboa, MD Niembro-Ortega, P Torres-González, ... PLoS neglected tropical diseases 15 (3), e0009215, 2021 | 39 | 2021 |
| The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis GR Aguilar, LR Swetschinski, ND Weaver, KS Ikuta, T Mestrovic, AP Gray, ... The Lancet Regional Health–Americas 25, 2023 | 35 | 2023 |
| Cirrhosis etiology trends in developing countries: Transition from infectious to metabolic conditions. Report from a multicentric cohort in central Mexico A Gonzalez-Chagolla, A Olivas-Martinez, J Ruiz-Manriquez, ... The Lancet Regional Health–Americas 7, 2022 | 32 | 2022 |
| Impact of the COVID-19 pandemic on the clinical training of last year medical students in Mexico: a cross-sectional nationwide study M Servin-Rojas, A Olivas-Martinez, M Dithurbide-Hernandez, ... BMC Medical Education 22 (1), 24, 2022 | 25 | 2022 |
| New 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline: Healthcare Impact in Mexico and Other Developing Countries AJ Martinez-Rueda, A Olivas-Martinez, O Vega-Vega, JI Fonseca-Correa, ... Hypertension 73 (1), 142-147, 2019 | 23 | 2019 |
| Cardiac resynchronization therapy improves outcomes in patients with intraventricular conduction delay but not right bundle branch block: a patient-level meta-analysis of … DJ Friedman, SM Al-Khatib, F Dalgaard, M Fudim, WT Abraham, ... Circulation 147 (10), 812-823, 2023 | 18 | 2023 |
| Outcomes in temporary ICUs versus conventional ICUs: an observational cohort of mechanically ventilated patients with COVID-19–induced acute respiratory distress syndrome JV Jimenez, A Olivas-Martinez, FA Rios-Olais, F Ayala-Aguillón, ... Critical Care Explorations 4 (4), e0668, 2022 | 15 | 2022 |
| Transplant trends in Mexico during the COVID-19 pandemic: disparities within healthcare sectors M Servin-Rojas, A Olivas-Martinez, FR Del Val, A Torres-Gomez, ... American Journal of Transplantation 21 (12), 4052-4060, 2021 | 15 | 2021 |
| Calculated versus measured urine osmolarity: accuracy of estimated urine density J de Jesús Vidal-Mayo, A Olivas-Martínez, I Pérez-Díaz, ... Revista de Investigación Clínica 70 (6), 310-318, 2018 | 15 | 2018 |
| Prevalence of metabolic-associated fatty liver disease in Mexico and development of a screening tool: the MAFLD-S score J Ruiz-Manriquez, A Olivas-Martinez, LC Chávez-García, ... Gastro Hep Advances 1 (3), 352-358, 2022 | 11 | 2022 |
| Liver transplantation in Mexico M Servin‐Rojas, A Olivas‐Martinez, L Toapanta‐Yanchapaxi, ... Clinical Liver Disease 19 (2), 53-58, 2022 | 10 | 2022 |
| The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories JV Lazarus, H Han, HE Mark, SA Alqahtani, JM Schattenberg, JB Soriano, ... Hepatology 78 (3), 911-928, 2023 | 9 | 2023 |
| Changing trends in etiology-based chronic liver disease from 2000 through 2019 in Mexico: multicenter study A Gonzalez Chagolla, A Olivas-Martinez, K Valenzuela-Vidales, ... Hepatology 72, 383A-384A, 2020 | 9 | 2020 |
| Causes of erythrocytosis and its impact as a risk factor for thrombosis according to etiology: experience in a referral center in Mexico City A Olivas-Martinez, E Corona-Rodarte, A Nuñez-Zuno, O Barrales-Benítez, ... Blood research 56 (3), 166-174, 2021 | 8 | 2021 |
| The influence of hospital antimicrobial use on carbapenem-non-susceptible Enterobacterales incidence rates according to their mechanism of resistance: a time-series analysis E Ortiz-Brizuela, Y Caro-Vega, M Bobadilla-del-Valle, F Leal-Vega, ... Journal of Hospital Infection 105 (4), 757-765, 2020 | 7 | 2020 |
